8-K: Interlink Electronics Reports 11% Q3 Revenue Growth, Strategic Wins
Quarterly Results
Interlink Electronics, Inc. announced its third quarter 2025 financial results, reporting an 11% year-over-year revenue increase and significant strategic advancements.
Summary
- Revenue for the third quarter of 2025 increased 11% year-over-year to $3.0 million, marking the second consecutive quarter of double-digit growth.
- The company reported a net loss of $336,000 for Q3 2025, an improvement from a net loss of $523,000 in the prior-year period.
- Adjusted EBITDA improved to $(62,000) in Q3 2025, compared to $(248,000) in Q3 2024.
- Interlink Electronics optimized its capital structure by converting all outstanding Series A Convertible Preferred Stock into common stock and issuing a 50% common stock dividend.
- The company secured two major SBIR grants: a $200,000 Phase 1 grant from the U.S. Food & Drug Administration (FDA) in October 2025 and a $175,000 grant from the United States Department of Agriculture (USDA) in September 2025.
- A Letter of Intent was signed to acquire a U.K.-based engineering and manufacturing company, aiming to strengthen Interlink's European footprint.
Sentiment
Score: 7
Explanation: The company shows strong positive momentum with double-digit revenue growth, improved profitability metrics (though still at a loss), strategic grant wins, and an active M&A pipeline. These factors indicate a positive trajectory and strategic execution, despite remaining unprofitable.
Positives
- Achieved 11% year-over-year revenue growth in Q3 2025, reaching $3.0 million, marking the second consecutive quarter of double-digit growth.
- Net loss improved by $187,000 to $(336,000) in Q3 2025 compared to $(523,000) in Q3 2024.
- Adjusted EBITDA improved by $186,000 to $(62,000) in Q3 2025 compared to $(248,000) in Q3 2024.
- Gross margin increased by 40 basis points to 41.8% in Q3 2025, driven by higher revenue and favorable product mix.
- Successfully converted all outstanding Series A Convertible Preferred Stock into common stock, simplifying the capital structure and enhancing shareholder alignment.
- Issued a 50% common stock dividend, further enhancing liquidity and strengthening shareholder value.
- Secured a $200,000 SBIR Phase 1 grant from the FDA in October 2025 for electrochemical sensors in food safety and quality monitoring.
- Awarded a $175,000 SBIR grant from the USDA in September 2025 to develop an AI-powered food quality & safety monitoring system.
- Signed a Letter of Intent to acquire a U.K.-based engineering and manufacturing company, expanding European capabilities and inorganic growth opportunities.
Negatives
- The company continues to operate at a net loss of $(336,000) and negative Adjusted EBITDA of $(62,000) in Q3 2025.
- Sales of gas-sensor products were lower, partially offsetting overall revenue growth.
- Revenue continues to fluctuate in response to changes in customer demand, order flow, and production cycles.
- Gross margin for the nine months ended September 30, 2025, decreased to 41.2% from 42.1% in the prior-year period.
Risks
- Success in predicting new markets and the acceptance of new products.
- Efficient management of infrastructure.
- The pace of technological developments and industry standards evolution and their effect on target product and market choices.
- The effect of outsourcing technology development.
- Changes in the ordering patterns of customers.
- A decrease in the quality and/or reliability of products.
- Protection of proprietary intellectual property.
- Competition by alternative sophisticated as well as generic products.
- Continued availability of raw materials for products at competitive prices.
- Disruptions in manufacturing facilities.
- Risks of international sales and operations, including fluctuations in exchange rates and tariffs.
- Compliance with regulatory requirements applicable to manufacturing operations.
- Customer concentrations.
Future Outlook
Entering 2026 from a position of strength, with momentum across product lines, strategic partnerships, and an expanding acquisition pipeline, Interlink Electronics anticipates a transformative period towards consistent profitability and scale.
Management Comments
- "The third quarter represented another step forward for Interlink."
- "We delivered our second consecutive quarter of double-digit year-over-year revenue growth, reflecting strong execution and growing demand across our core sensor and printed electronics platforms."
- "In parallel, we secured two competitive U.S. government SBIR grants, underscoring our leadership in innovation and the expanding applicability of our technologies in new markets such as food quality and safety."
- "We also took important steps to strengthen our balance sheet and enhance shareholder alignment by converting all outstanding Series A Convertible Preferred Stock into common stock and issuing a 50% common-stock dividend. These actions simplify our capital structure, improve liquidity, and further position Interlink for sustained growth."
- "Looking ahead, we are entering 2026 from a position of strength. With momentum across our product lines, a growing base of strategic partnerships, and an expanding pipeline of acquisition opportunities, we believe the coming year will be a transformative period for Interlink as we move toward consistent profitability and scale."
Industry Context
Interlink Electronics operates in the dynamic sensor technology and printed electronics industry, serving diverse markets including medical, industrial, automotive, wearables, and IoT. The company's recent SBIR grants from the FDA and USDA highlight its expansion into emerging high-growth areas like food quality and safety monitoring, leveraging its core expertise in materials science and embedded electronics. The active pursuit of M&A opportunities, exemplified by the Letter of Intent for a U.K.-based company, indicates a strategy to strengthen its global footprint and capabilities in a competitive and consolidating technology landscape.
Comparison to Industry Standards
- The filing does not contain specific comparable companies, projects, or results to global benchmarks, therefore a direct assessment against industry standards with specific entities is not possible based solely on this document.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Capital Structure Optimization | Converted all outstanding Series A Convertible Preferred Stock into common stock, eliminating overhang and enhancing alignment with shareholders. | November 12, 2025 | Simplifies the capital structure, improves liquidity, and strengthens shareholder value by increasing common stock ownership and reducing potential dilution from preferred shares. |
| Shareholder Value Enhancement | Issued a 50% common stock dividend. | November 12, 2025 | Further enhances liquidity for common shareholders and strengthens shareholder value by increasing the number of shares held. |
Stakeholder Impact
- Shareholders: Enhanced alignment and liquidity through preferred stock conversion and common stock dividend; potential for increased value from strategic growth and M&A.
- Employees: Potential for growth and expansion through M&A and new market penetration.
- Customers: Continued innovation and expanded product offerings, particularly in food safety and quality monitoring.
- Potential Acquisition Targets: Opportunities for integration into Interlink's growing European footprint and capabilities.
Next Steps
- Actively evaluate and pursue a growing pipeline of acquisition opportunities that align with long-term shareholder value.
- Continue building momentum across product lines and strategic partnerships.
- Move toward consistent profitability and scale in 2026, which is anticipated to be a transformative period.
Key Dates
| Date | Description |
|---|---|
| 2023 | Acquisition of Calman Technology. |
| September 2025 | Awarded a $175,000 SBIR grant from the United States Department of Agriculture (USDA). |
| September 30, 2025 | End of the third fiscal quarter for which results are reported. |
| October 2025 | Received a $200,000 SBIR Phase 1 grant from the U.S. Food & Drug Administration (FDA). |
| November 12, 2025 | Date of report and announcement of financial results for the quarter ended September 30, 2025. |
| 2026 | Expected to be a transformative period for Interlink, moving toward consistent profitability and scale. |
Recommendation
holdInterlink Electronics demonstrates strong operational improvements with double-digit revenue growth and reduced net losses, alongside strategic wins like SBIR grants and an active M&A pipeline. These factors indicate positive momentum and a clear growth strategy. However, the company remains unprofitable, and its future outlook for 'consistent profitability and scale' is forward-looking. A 'hold' recommendation is appropriate for investors to observe the execution of its M&A strategy and progress towards sustained profitability in 2026, balancing the positive trends against the current unprofitability.
Keywords
sensor technology, printed electronics, Q3 2025 results, revenue growth, SBIR grants, food safety, M&A, capital structure, NASDAQ:LINK, force-sensing products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.